Corvus Pharmaceuticals, Inc. (CRVS) shares outstanding

Shares outstanding · fiscal 2025
79.74M

Corvus Pharmaceuticals, Inc. (CRVS) had 79.74M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 30.8% higher than the 60.99M of fiscal 2024. Figures as of 18 Nov 2026, 12:43 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
79.74M
Change on fiscal 2024
+30.8%
Growth, 5 years
+22.0% a year
Highest on record
79.74Mfiscal 2025
Lowest on record
29.35Mfiscal 2019
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Corvus Pharmaceuticals, Inc. shares outstanding, in more detail

The market data feed counts 84.35M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 22.0% a year. Across the 7 fiscal years on record (2019–2025), the highest was 79.74M in fiscal 2025 and the lowest 29.35M in fiscal 2019.

History · 7 fiscal years

Shares outstanding by fiscal year

Corvus Pharmaceuticals, Inc. shares outstanding, year by year

Corvus Pharmaceuticals, Inc. (CRVS) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202579.74M 30.8% up
202460.99M 27.0% up
202348.03M 3.2% up
202246.55M 11.2% up
202141.85M 42.0% up
202029.48M 0.4% up
201929.35M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on CRVS

Corvus Pharmaceuticals, Inc., figure by figure

Corvus Pharmaceuticals, Inc. (CRVS) overview: price, valuation and scorecard

Corvus Pharmaceuticals, Inc. shares outstanding: questions and answers

How many shares does Corvus Pharmaceuticals, Inc. have?

Corvus Pharmaceuticals, Inc. (CRVS) had 79.74M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 30.8% higher than the 60.99M of fiscal 2024. The market data feed counts 84.35M shares outstanding today.

What is the growth rate of Corvus Pharmaceuticals, Inc.'s diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 22.0% a year.

What are the highest and lowest diluted share count figures on record for Corvus Pharmaceuticals, Inc.?

Across the 7 fiscal years on record (2019–2025), the highest was 79.74M in fiscal 2025 and the lowest 29.35M in fiscal 2019.

How is Corvus Pharmaceuticals, Inc.'s diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Corvus Pharmaceuticals, Inc. it is on record here for 7 fiscal years, 2019 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Corvus Pharmaceuticals, Inc. (CRVS) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/CRVS/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.